Literature DB >> 11713280

Cross talk between beta-adrenergic and bradykinin B(2) receptors results in cooperative regulation of cyclic AMP accumulation and mitogen-activated protein kinase activity.

S Hanke1, B Nürnberg, D H Groll, C Liebmann.   

Abstract

Costimulation of G protein-coupled receptors (GPCRs) may result in cross talk interactions between their downstream signaling pathways. Stimulation of GPCRs may also lead to cross talk regulation of receptor tyrosine kinase signaling and thereby to activation of mitogen-activated protein kinase (MAPK). In COS-7 cells, we investigated the interactions between two particular mitogenic receptor pathways, the endogenously expressed beta-adrenergic receptor (beta-AR) and the transiently transfected human bradykinin (BK) B(2) receptor (B(2)R). When beta-AR and B(2)R are costimulated, we found two different cross talk mechanisms. First, the predominantly G(q) protein-coupled B(2)R is enabled to activate a G(i) protein and, subsequently, type II adenylate cyclase. This results in augmentation of beta-AR-mediated cyclic AMP (cAMP) accumulation by BK, which alone is unable to increase the cAMP level. Second, independently of BK-induced superactivation of the cAMP system, costimulation of beta-AR leads to protein kinase A-mediated blockade of phospholipase C activation by BK. Thereby, the pathway from B(2)R to MAPK, which essentially involves protein kinase C activation, is selectively switched off. The MAPK activation in response to isoproterenol was not affected due to costimulation. Furthermore, in the presence of isoproterenol, BK lost its ability to stimulate DNA synthesis in COS-7 cells. Thus, our findings might establish a novel paradigm: cooperation between simultaneously activated mitogenic pathways may prevent multiple stimulation of MAPK activity and increased cell growth.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11713280      PMCID: PMC100008          DOI: 10.1128/MCB.21.24.8452-8460.2001

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  32 in total

1.  Expression and functional characterization of a pHis-tagged human bradykinin B2 receptor in COS-7 cells.

Authors:  S Müller; A Adomeit; R Kaufmann; H Appelhans; H Passow; S Reissmann; C Liebmann
Journal:  Biol Chem       Date:  2000-04       Impact factor: 3.915

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  A high-affinity bradykinin receptor in membranes from rat myometrium is coupled to pertussis toxin-sensitive G-proteins of the Gi family.

Authors:  C Liebmann; S Offermanns; K Spicher; K D Hinsch; M Schnittler; J L Morgat; S Reissmann; G Schultz; W Rosenthal
Journal:  Biochem Biophys Res Commun       Date:  1990-03-30       Impact factor: 3.575

4.  The beta(2)-adrenergic receptor mediates extracellular signal-regulated kinase activation via assembly of a multi-receptor complex with the epidermal growth factor receptor.

Authors:  S Maudsley; K L Pierce; A M Zamah; W E Miller; S Ahn; Y Daaka; R J Lefkowitz; L M Luttrell
Journal:  J Biol Chem       Date:  2000-03-31       Impact factor: 5.157

5.  Signal transduction in G0/G1-arrested mouse Y1 adrenocortical cells stimulated by ACTH and FGF2.

Authors:  A P Lepique; F L Forti; M S Moraes; H A Armelin
Journal:  Endocr Res       Date:  2000-11       Impact factor: 1.720

6.  In various tumour cell lines the peptide bradykinin B(2) receptor antagonist, Hoe 140 (Icatibant), may act as mitogenic agonist.

Authors:  S Drube; C Liebmann
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

7.  G protein-coupled receptor-mediated mitogen-activated protein kinase activation through cooperation of Galpha(q) and Galpha(i) signals.

Authors:  A Blaukat; A Barac; M J Cross; S Offermanns; I Dikic
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

8.  beta 2-adrenergic receptor activates extracellular signal-regulated kinases (ERKs) via the small G protein rap1 and the serine/threonine kinase B-Raf.

Authors:  J M Schmitt; P J Stork
Journal:  J Biol Chem       Date:  2000-08-18       Impact factor: 5.157

9.  Cyclic AMP inhibits inositol polyphosphate production and calcium mobilization in neuroblastoma X glioma NG108-15 cells.

Authors:  M D Campbell; S Subramaniam; M I Kotlikoff; J R Williamson; S J Fluharty
Journal:  Mol Pharmacol       Date:  1990-08       Impact factor: 4.436

10.  A novel regulatory mechanism of MAP kinases activation and nuclear translocation mediated by PKA and the PTP-SL tyrosine phosphatase.

Authors:  C Blanco-Aparicio; J Torres; R Pulido
Journal:  J Cell Biol       Date:  1999-12-13       Impact factor: 10.539

View more
  3 in total

1.  High-level activation of cyclic AMP signaling attenuates bone morphogenetic protein 2-induced sympathoadrenal lineage development and promotes melanogenesis in neural crest cultures.

Authors:  Ming Ji; Ourania M Andrisani
Journal:  Mol Cell Biol       Date:  2005-06       Impact factor: 4.272

2.  Activation of β-adrenergic receptor promotes cellular proliferation in human glioblastoma.

Authors:  Jing-Jing He; Wen-Hua Zhang; Shi-Ling Liu; Yi-Fang Chen; Chen-Xi Liao; Qian-Qing Shen; Ping Hu
Journal:  Oncol Lett       Date:  2017-07-21       Impact factor: 2.967

3.  Bradykinin B2 and GPR100 receptors: a paradigm for receptor signal transduction pharmacology.

Authors:  Stefania Meini; Francesca Bellucci; Paola Cucchi; Sandro Giuliani; Laura Quartara; Alessandro Giolitti; Sabrina Zappitelli; Luigi Rotondaro; Katrin Boels; Carlo Alberto Maggi
Journal:  Br J Pharmacol       Date:  2004-11-15       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.